Back to Screener

Healthcare

Inspire Medical Systems, Inc.(INSP)

Live Price

Offline

$45.72

+5.22% today

1Y Change

-64.77%

Window

Jun 30, 2025 โ†’ Jun 26, 2026

Market Cap
$1.62B
Revenue Growth
+13.6%
EPS Growth
+175.0%
Dividend Yield
0.0%

Coverage: 249 bars ยท Jun 30, 2025 โ†’ Jun 26, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Inspire Medical Systems, Inc. (INSP) is a Healthcare stock with a market cap of $1.62B and listed on NYSE. The stock last traded around $45.72 and down 64.8% across the available one-year price window (Jun 30, 2025 โ†’ Jun 26, 2026). Baseline metrics include revenue growth of +13.6%, EPS growth of +175.0%, a dividend yield of 0.0%. What stands out right now is revenue +13.6%, EPS +175.0%, free cash flow -13.9% with operating margin 5.6% and ROIC 6.2%. Valuation is more restrained than many high-expectation growth names at P/E 11.2 and price/sales 1.8. Stock Foundry combines INSP price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

INSP vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

Relative Read

INSP trails SPY

INSP is 82.76 pts behind over the shared 1Y window.

INSP had 63.05 pts deeper max drawdown than SPY.

INSP beat SPY in 0 of 2 calendar years shown and trailed in 2.

INSP

-64.77%

Normalized return

SPY

+17.99%

S&P 500

Excess Return

-82.76 pts

Relative to SPY

INSP Max Drawdown

-72.19%

Trailing 1Y

SPY Max Drawdown

-9.13%

Trailing 1Y

INSPSPY

Calendar-Year Returns

Uses the longest available daily history for INSP and SPY.

YearINSPSPYExcessLeader
2026-50.45%+6.71%-57.16 ptsSPY
2025-28.67%+11.19%-39.86 ptsSPY

Unable to load analyst forecasts.

Timed out loading forecasts for INSP

Next Step

Put consensus data in context

Forecasts are most valuable when they sit beside comparisons, earnings setup, and the rest of the business story.